These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6099709

  • 1. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
    Prusoff WH, Mancini WR, Lin TS, Lee JJ, Siegel SA, Otto MJ.
    Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
    [Abstract] [Full Text] [Related]

  • 2. Nucleoside analogues as antiviral agents.
    de Clercq E.
    Acta Microbiol Acad Sci Hung; 1981 Dec; 28(3):289-306. PubMed ID: 6272552
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J, De Clercq E, Verbruggen A, Ayusawa D, Shimizu K, Seno T.
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [Abstract] [Full Text] [Related]

  • 10. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM, Fleming HE, Leslie LK, Retondo MJ.
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
    Suzutani T, Machida H, Sakuma T.
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1046-52. PubMed ID: 2847637
    [Abstract] [Full Text] [Related]

  • 13. The relationship between the antiviral activity of 5'-amino-5'-deoxythymidine and its incorporation into herpes simplex virus type 1 DNA.
    Otto MJ, Prusoff WH.
    Antiviral Res; 1984 Oct; 4(5):271-80. PubMed ID: 6097180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific herpes simplex virus-induced incorporation of 5-iodo-5'-amino-2',5'-dideoxyuridine into deoxyribonucleic acid.
    Chen MS, Ward DC, Prusoff WH.
    J Biol Chem; 1976 Aug 25; 251(16):4833-8. PubMed ID: 182681
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
    Schinazi RF, Fox JJ, Watanabe KA, Nahmias AJ.
    Antimicrob Agents Chemother; 1986 Jan 25; 29(1):77-84. PubMed ID: 3015003
    [Abstract] [Full Text] [Related]

  • 19. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
    La Colla P, Gelli G, Mura L, Landini MP, Corrias MV, Pani A, Marongiu ME.
    Antiviral Res; 1985 Jan 25; Suppl 1():29-34. PubMed ID: 3002262
    [No Abstract] [Full Text] [Related]

  • 20. Antiviral activity of 5-iodo-2'-deoxyuridine and related drugs in human keratinocytes infected in vitro with herpes simplex virus type 1.
    Reuveni H, Bull CO, Landry ML, Milstone LM, Schwartz PM.
    Skin Pharmacol; 1991 Jan 25; 4(4):291-7. PubMed ID: 1665069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.